• Search
  • Helpdesk
  • Sales contact
Get your demo
☰

White Paper

Innovation and Partnerships: The Biotech Perspective

biotechCardiology
In the ever-evolving landscape of biotechnology, groundbreaking advancements continue to shape the future of healthcare. In this exclusive interview, Estelle Haenel, Chief Medical Officer at Kayentis, engages in a profound...

ePRO data collection: Decision-making for the adoption of a Bring Your Own Device (BYOD) strategy

BYOD
Electronic devices have been systematically provided to participants to report Patient Reported Outcome (PRO) data in clinical trials and electronic...
,

Decentralized Clinical Trials
Essential tips to avoid common pitfalls

Scientific advice
Despite the numerous advantages of Decentralized Clinical Trials, reducing on-site visit means that data endpoints need to be captured via...

Do we have the right understanding of how patients perceive digital clinical trials?

Patients insights
Interview with Trishna Bharadia, Health Advocate & Patient Engagement Advisor on the 1,133 patients survey results conducted by Kayentis in...

BYOD: When, why and how?

BYOD
What are the main characteristics that make BYOD a strong feature for decentralized trials? What are the key factors to...

eCOA back-up strategies

No longer the “what if” situation: today’s reality and eCOA back-up strategies.How to ensure they are adapted? There have always...

eCOA set-up #whitepaper

Project management
How to anticipate eCOA complexities and ensure a successful launch? Setting up a study with eCOA should be straight forward:...

eCOA challenges of long term studies #whitepaper

OncologyProject management
How to anticipate eCOA complexities in multi-year studies & develop best practice to support sites? Using eCOA solutions can bring...
Follow us on social media
Subscribe to our newsletter
You may also like

Rare disease clinical research: it is time to tackle what...

Biotech and eCOA vendor: A shared mindset

The client’s voice: why they consistently choose Kayentis

Why you should join Kayentis

Rethinking pediatric clinical trials: guidelines from pediatric experts

Overcoming challenges in long-lasting pediatric clinical trials – Insights from...

About the author
Picture of Marc Chaperon

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA